A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.
about
Stem cells in genetically-engineered mouse models of prostate cancerConcise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsHydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening.Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cellsSingle luminal epithelial progenitors can generate prostate organoids in culture.Molecular pathways and targets in prostate cancerRecent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer.A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors.Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.Therapeutic Approaches Targeting MYC-Driven Prostate CancerThe transcriptional programme of the androgen receptor (AR) in prostate cancer.Biomarkers and mechanisms associated with recurrent prostate cancer.Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer.Castrate-tolerant cells: what are the implications for the treatment of localized prostate cancer?Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.[Novel preclinical models and biomarkers for prostate cancer].Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research
P2860
Q26784057-5C6A63A8-4E08-4308-9279-A08B80D699B3Q28088370-6FC9D03B-070F-4710-A148-E56B081BEDC9Q33894635-9D2802A5-21AC-4A0C-9A07-998D1212DE8CQ33988851-C9D4DB02-2AC2-42D5-AC10-91E22432F815Q34282951-A2C0CF21-2CB6-4918-827F-81A73296CF5CQ34365632-859ACDE5-DCF2-4F3B-8A57-380DF236E4FCQ34495028-F01DEFA7-2A16-4D5A-AE94-831CDA43EE56Q35754996-72DF04EB-9A7C-48C8-B3AD-7E34F63D18C2Q36825219-6998E9F5-7D36-43E6-96CE-783BF11C9D7DQ37565228-CB9AA98F-00ED-4555-91DE-2E04EAF16F8EQ37676253-E133E082-2911-4CF0-A19A-88C5BE93BE67Q38140106-D5BFF767-8C58-4F6A-888A-9E2175F69AE5Q38175727-D9DB6F79-DA56-4600-8084-617781F3BE66Q38321512-35535FFB-7412-4BF1-85FF-167795104EB5Q39634850-1DA0B2B9-6B84-4FB5-9698-7B154D18F3C3Q42140255-C349ABC3-05B1-427F-BBD1-BC0E9765C8C8Q42175087-71B48A4E-BC0E-46D7-A886-4BDBE873974AQ42510877-ADC240B9-82AA-43E8-8D30-3CA7C408CD3EQ44582971-593E2983-3ED1-44DA-973D-F1A0CFD402E3Q48244745-EA9B68F7-C61F-4B50-B06F-A0A5C034F0E2Q50577685-ABEEF695-508B-45B6-8DB1-77B8AD4F4B39Q55237889-B948A184-DC4D-451A-96F7-902CE78ED7BAQ58804592-7075CAB6-842B-4682-805E-5AAD1B7F10C8
P2860
A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A preclinical xenograft model ...... in localized prostate tumors.
@en
A preclinical xenograft model ...... in localized prostate tumors.
@nl
type
label
A preclinical xenograft model ...... in localized prostate tumors.
@en
A preclinical xenograft model ...... in localized prostate tumors.
@nl
prefLabel
A preclinical xenograft model ...... in localized prostate tumors.
@en
A preclinical xenograft model ...... in localized prostate tumors.
@nl
P2093
P2860
P1476
A preclinical xenograft model ...... s in localized prostate tumors
@en
P2093
Andrew Ryan
Australian Prostate Cancer BioResource
David M Berman
David Pook
John Pedersen
Mark Frydenberg
Renea A Taylor
Roxanne Toivanen
P2860
P304
P356
10.1126/SCITRANSLMED.3005688
P407
P577
2013-05-01T00:00:00Z